NVS logo

Novartis AG (NVS) Net income

annual net income:

$11.93B+$3.36B(+39.20%)
December 31, 2024

Summary

  • As of today (August 21, 2025), NVS annual net profit is $11.93 billion, with the most recent change of +$3.36 billion (+39.20%) on December 31, 2024.
  • During the last 3 years, NVS annual net income has fallen by -$12.09 billion (-50.32%).
  • NVS annual net income is now -50.32% below its all-time high of $24.02 billion, reached on December 31, 2021.

Performance

NVS Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

quarterly net income:

$4.09B+$479.61M(+13.29%)
June 30, 2025

Summary

  • As of today (August 21, 2025), NVS quarterly net profit is $4.09 billion, with the most recent change of +$479.61 million (+13.29%) on June 30, 2025.
  • Over the past year, NVS quarterly net income has increased by +$842.61 million (+25.96%).
  • NVS quarterly net income is now -74.93% below its all-time high of $16.31 billion, reached on December 31, 2021.

Performance

NVS quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

TTM net income:

$13.68B+$842.61M(+6.56%)
June 30, 2025

Summary

  • As of today (August 21, 2025), NVS TTM net profit is $13.68 billion, with the most recent change of +$842.61 million (+6.56%) on June 30, 2025.
  • Over the past year, NVS TTM net income has increased by +$3.60 billion (+35.67%).
  • NVS TTM net income is now -43.41% below its all-time high of $24.18 billion, reached on March 31, 2022.

Performance

NVS TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

NVS Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.2%+26.0%+35.7%
3 y3 years-50.3%+141.2%-40.5%
5 y5 years+67.0%+119.0%+89.8%

NVS Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-50.3%+97.3%at high+210.9%-40.5%+110.7%
5 y5-year-50.3%+97.3%-74.9%+210.9%-43.4%+110.7%
alltimeall time-50.3%+539.4%-74.9%+550.0%-43.4%+987.6%

NVS Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.09B(+13.3%)
$13.68B(+6.6%)
Mar 2025
-
$3.61B(+28.9%)
$12.84B(+7.7%)
Dec 2024
$11.93B(+39.2%)
$2.80B(-12.1%)
$11.92B(+1.4%)
Sep 2024
-
$3.19B(-1.9%)
$11.76B(+16.6%)
Jun 2024
-
$3.25B(+20.8%)
$10.09B(+10.7%)
Mar 2024
-
$2.69B(+1.9%)
$9.11B(+6.2%)
Dec 2023
$8.57B(+41.7%)
$2.64B(+74.4%)
$8.58B(+18.2%)
Sep 2023
-
$1.51B(-33.3%)
$7.25B(+2.6%)
Jun 2023
-
$2.27B(+5.3%)
$7.07B(+8.8%)
Mar 2023
-
$2.16B(+63.9%)
$6.50B(-1.0%)
Dec 2022
$6.05B(-74.8%)
$1.31B(-1.1%)
$6.56B(-69.6%)
Sep 2022
-
$1.33B(-21.5%)
$21.55B(-6.2%)
Jun 2022
-
$1.70B(-23.6%)
$22.98B(-5.0%)
Mar 2022
-
$2.22B(-86.4%)
$24.18B(+0.7%)
Dec 2021
$24.02B(+197.6%)
$16.31B(+491.2%)
$24.02B(+144.8%)
Sep 2021
-
$2.76B(-4.7%)
$9.81B(+9.2%)
Jun 2021
-
$2.90B(+40.6%)
$8.98B(+12.9%)
Mar 2021
-
$2.06B(-1.9%)
$7.96B(-1.4%)
Dec 2020
$8.07B(+12.9%)
$2.10B(+8.6%)
$8.07B(+13.7%)
Sep 2020
-
$1.93B(+3.5%)
$7.10B(-1.5%)
Jun 2020
-
$1.87B(-14.1%)
$7.21B(-3.2%)
Mar 2020
-
$2.17B(+92.5%)
$7.45B(+4.3%)
Dec 2019
$7.15B(-44.2%)
$1.13B(-44.7%)
$7.15B(-1.3%)
Sep 2019
-
$2.04B(-3.2%)
$7.24B(+2.2%)
Jun 2019
-
$2.11B(+12.9%)
$7.08B(-44.3%)
Mar 2019
-
$1.87B(+53.1%)
$12.70B(-0.8%)
Dec 2018
$12.80B(+66.2%)
$1.22B(-35.2%)
$12.80B(-5.6%)
Sep 2018
-
$1.88B(-75.6%)
$13.56B(-1.5%)
Jun 2018
-
$7.73B(+292.3%)
$13.76B(+71.8%)
Mar 2018
-
$1.97B(-0.3%)
$8.01B(+4.0%)
Dec 2017
$7.70B(+15.0%)
$1.98B(-5.1%)
$7.70B(+15.6%)
Sep 2017
-
$2.08B(+5.3%)
$6.66B(+2.1%)
Jun 2017
-
$1.98B(+18.9%)
$6.53B(+2.7%)
Mar 2017
-
$1.67B(+77.9%)
$6.35B(-5.2%)
Dec 2016
$6.70B(-4.7%)
$936.00M(-51.9%)
$6.70B(-1.7%)
Sep 2016
-
$1.95B(+7.7%)
$6.82B(+2.0%)
Jun 2016
-
$1.81B(-10.2%)
$6.68B(-0.7%)
Mar 2016
-
$2.01B(+90.8%)
$6.73B(-4.2%)
Dec 2015
$7.03B(-34.5%)
$1.05B(-41.8%)
$7.03B(-16.6%)
Sep 2015
-
$1.81B(-2.4%)
$8.42B(-13.3%)
Jun 2015
-
$1.86B(-19.5%)
$9.71B(-8.6%)
Mar 2015
-
$2.31B(-5.8%)
$10.63B(-6.5%)
Dec 2014
$10.73B(+15.2%)
$2.45B(-21.1%)
$11.37B(+4.0%)
Sep 2014
-
$3.10B(+11.8%)
$10.94B(+9.4%)
Jun 2014
-
$2.78B(-8.8%)
$9.99B(+1.9%)
Mar 2014
-
$3.04B(+51.1%)
$9.81B(+6.6%)
Dec 2013
$9.31B(-0.8%)
$2.02B(-6.7%)
$9.20B(-0.1%)
Sep 2013
-
$2.16B(-16.5%)
$9.20B(-1.8%)
Jun 2013
-
$2.59B(+6.3%)
$9.37B(+0.4%)
Mar 2013
-
$2.43B(+20.4%)
$9.34B(+3.1%)
Dec 2012
$9.38B(+2.6%)
$2.02B(-13.1%)
$9.05B(+10.5%)
Sep 2012
-
$2.33B(-8.8%)
$8.19B(-4.2%)
Jun 2012
-
$2.55B(+18.7%)
$8.56B(-4.3%)
Mar 2012
-
$2.15B(+84.8%)
$8.94B(-8.6%)
DateAnnualQuarterlyTTM
Dec 2011
$9.15B(-7.5%)
$1.16B(-56.7%)
$9.78B(-11.3%)
Sep 2011
-
$2.69B(-8.4%)
$11.03B(+3.1%)
Jun 2011
-
$2.94B(-1.9%)
$10.69B(+6.0%)
Mar 2011
-
$2.99B(+24.5%)
$10.08B(+0.5%)
Dec 2010
$9.89B(+17.4%)
$2.40B(+2.1%)
$10.04B(-0.5%)
Sep 2010
-
$2.36B(+1.2%)
$10.09B(+2.6%)
Jun 2010
-
$2.33B(-21.0%)
$9.83B(+3.0%)
Mar 2010
-
$2.95B(+19.8%)
$9.55B(+11.3%)
Dec 2009
$8.42B(+3.2%)
$2.46B(+17.4%)
$8.58B(+12.5%)
Sep 2009
-
$2.10B(+2.5%)
$7.62B(-0.3%)
Jun 2009
-
$2.05B(+3.6%)
$7.64B(-2.9%)
Mar 2009
-
$1.98B(+31.1%)
$7.87B(-3.3%)
Dec 2008
$8.16B(+24.8%)
$1.51B(-28.8%)
$8.14B(+7.6%)
Sep 2008
-
$2.12B(-6.9%)
$7.56B(+7.7%)
Jun 2008
-
$2.27B(+1.4%)
$7.02B(+5.0%)
Mar 2008
-
$2.24B(+140.8%)
$6.68B(+1.6%)
Dec 2007
$6.54B(-4.2%)
$931.00M(-40.9%)
$6.58B(-9.2%)
Sep 2007
-
$1.57B(-18.7%)
$7.24B(-2.9%)
Jun 2007
-
$1.94B(-9.4%)
$7.46B(+4.3%)
Mar 2007
-
$2.14B(+33.9%)
$7.16B(+4.3%)
Dec 2006
$6.83B(+12.4%)
$1.60B(-11.0%)
$6.86B(+4.8%)
Sep 2006
-
$1.79B(+9.9%)
$6.55B(+2.0%)
Jun 2006
-
$1.63B(-11.3%)
$6.42B(+0.3%)
Mar 2006
-
$1.84B(+43.4%)
$6.40B(+5.3%)
Dec 2005
$6.07B(+13.5%)
$1.28B(-23.0%)
$6.08B(-0.7%)
Sep 2005
-
$1.67B(+3.2%)
$6.12B(+3.6%)
Jun 2005
-
$1.61B(+6.2%)
$5.91B(+0.8%)
Mar 2005
-
$1.52B(+14.8%)
$5.86B(+3.0%)
Dec 2004
$5.35B(+6.5%)
$1.32B(-9.0%)
$5.69B(-1.1%)
Sep 2004
-
$1.45B(-7.1%)
$5.75B(+2.4%)
Jun 2004
-
$1.57B(+16.3%)
$5.62B(+3.3%)
Mar 2004
-
$1.35B(-2.8%)
$5.44B(+4.0%)
Dec 2003
$5.02B(+6.5%)
$1.38B(+4.9%)
$5.23B(+4.4%)
Sep 2003
-
$1.32B(-4.8%)
$5.01B(+2.6%)
Jun 2003
-
$1.39B(+22.0%)
$4.88B(+1.9%)
Mar 2003
-
$1.14B(-2.3%)
$4.79B(+1.5%)
Dec 2002
$4.72B(+13.0%)
$1.16B(-2.3%)
$4.71B(+12.8%)
Sep 2002
-
$1.19B(-8.1%)
$4.18B(+1.5%)
Jun 2002
-
$1.30B(+21.8%)
$4.12B(+6.7%)
Mar 2002
-
$1.06B(+69.2%)
$3.86B(-0.2%)
Dec 2001
$4.17B(-2.8%)
$629.00M(-44.2%)
$3.87B(-12.2%)
Sep 2001
-
$1.13B(+8.6%)
$4.40B(+6.1%)
Jun 2001
-
$1.04B(-3.0%)
$4.15B(-5.5%)
Mar 2001
-
$1.07B(-8.0%)
$4.39B(-4.1%)
Dec 2000
$4.29B(-3.5%)
$1.16B(+32.9%)
$4.58B(+34.1%)
Sep 2000
-
$876.00M(-31.7%)
$3.42B(+34.5%)
Jun 2000
-
$1.28B(+1.9%)
$2.54B(+101.9%)
Mar 2000
-
$1.26B
$1.26B
Dec 1999
$4.45B(+5.8%)
-
-
Dec 1998
$4.20B(+16.6%)
-
-
Dec 1997
$3.60B(+93.2%)
-
-
Dec 1996
$1.87B(-47.9%)
-
-
Dec 1995
$3.58B(+32.3%)
-
-
Dec 1994
$2.70B(+13.8%)
-
-
Dec 1993
$2.38B
-
-

FAQ

  • What is Novartis AG annual net profit?
  • What is the all time high annual net income for Novartis AG?
  • What is Novartis AG annual net income year-on-year change?
  • What is Novartis AG quarterly net profit?
  • What is the all time high quarterly net income for Novartis AG?
  • What is Novartis AG quarterly net income year-on-year change?
  • What is Novartis AG TTM net profit?
  • What is the all time high TTM net income for Novartis AG?
  • What is Novartis AG TTM net income year-on-year change?

What is Novartis AG annual net profit?

The current annual net income of NVS is $11.93B

What is the all time high annual net income for Novartis AG?

Novartis AG all-time high annual net profit is $24.02B

What is Novartis AG annual net income year-on-year change?

Over the past year, NVS annual net profit has changed by +$3.36B (+39.20%)

What is Novartis AG quarterly net profit?

The current quarterly net income of NVS is $4.09B

What is the all time high quarterly net income for Novartis AG?

Novartis AG all-time high quarterly net profit is $16.31B

What is Novartis AG quarterly net income year-on-year change?

Over the past year, NVS quarterly net profit has changed by +$842.61M (+25.96%)

What is Novartis AG TTM net profit?

The current TTM net income of NVS is $13.68B

What is the all time high TTM net income for Novartis AG?

Novartis AG all-time high TTM net profit is $24.18B

What is Novartis AG TTM net income year-on-year change?

Over the past year, NVS TTM net profit has changed by +$3.60B (+35.67%)
On this page